Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Seikagaku Corp banner

Seikagaku Corp
TSE:4548

Watchlist Manager
Seikagaku Corp Logo
Seikagaku Corp
TSE:4548
Watchlist
Price: 723 JPY 0.42%
Market Cap: ¥41.1B
Write Note Create Alert Ask AI

Seikagaku Corp
Investor Relations

Seikagaku Corp. manufactures pharmaceuticals and medical devices with glycoconjugates; specifically, glycosaminoglycans (GAG) such as hyaluronic acid; as well as enzymes that act on GAG. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 913 full-time employees. The company went IPO on 2004-03-23. The firm operates in two business segments. The Pharmaceutical business segment provides hyaluronan-based medicines for joint function improvement, ophthalmic operation boosters and submucosal injection materials for endoscopes, as well as drug substances for various pharmaceuticals. The LAL business segment provides reagents for measuring endotoxin.

Show more
Loading
4548
Nikkei 225
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Kenji Mizutani
President, CEO & Representative Director
No Bio Available
Kazushi Takeda
Executive Vice President of HR, F&A and Corporate Staff
No Bio Available
Ryoji Tomokiyo
Executive Vice President of Business Development & Marketing
No Bio Available
Yuji Shimojima
Executive Vice President of Quality Compliance & Medical Affairs
No Bio Available
Mr. Toshiyuki Okada
Managing Executive Officer & Director
No Bio Available
Mr. Yosuke Funakoshi
Senior Executive Officer, GM of Research & Development and Director
No Bio Available
Masayuki Ito
Executive VP & Head of Production
No Bio Available

Contacts

Address
TOKYO-TO
Chiyoda-ku
10F, Marunouchi Center Bldg., 1-6-1, Marunouchi
Contacts
+81352208950.0
www.seikagaku.co.jp
sparklesyt

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 319,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.